Fevertree trading inline with guidance intact

Fevertree Drinks Plc reported trading in line with expectations, forecasting low single-digit revenue growth and an adjusted EBITDA margin of around 12% for the fiscal year. The company highlighted strong US momentum, progress in its Molson Coors partnership, and its leading position in the UK, while noting solid performances in the Netherlands and France, offset by softness in Germany. Fevertree has executed £42.5 million of its £100 million share buyback program and intends to retain sufficient cash for investment and M&A opportunities.

Analysis

Fevertree Drinks Plc has confirmed its trading is aligned with current market expectations, reiterating its full-year guidance for low single-digit revenue growth and an adjusted EBITDA margin of approximately 12%. The company highlighted significant positive momentum in the US market, with brand performance reportedly outpacing competitors and its partnership with Molson Coors showing initial progress during a key transitional period. In its home market, the UK, Fevertree maintains its leading position, achieving growth across both alcoholic and non-alcoholic beverage segments. International operations are also advancing, evidenced by the commencement of in-country production in Australia, and solid performances noted in the Netherlands and France, although the German market continues to exhibit softness. Regarding capital returns, Fevertree has executed approximately £42.5 million of its £100 million share buyback program announced earlier in 2025. The company's capital allocation strategy remains focused on retaining adequate cash for investment opportunities, including increased marketing in growth regions, while also actively seeking M&A opportunities to support its strategic objectives. The overall sentiment from this update is moderately positive, suggesting operational stability and a clear focus on strategic growth drivers.

Key Decisions for Investors

• Investors should closely monitor the US market progress, particularly the maturation and impact of the Molson Coors partnership, as this is presented as a key growth vector.
• Evaluate the effectiveness of increased marketing expenditure in growth regions and its correlation with achieving the stated revenue and EBITDA margin targets.
• Consider the ongoing share buyback's influence on shareholder value and remain alert for potential M&A announcements that could alter the company's growth trajectory or financial structure.
• Track developments in the German market to assess if the current softness is a transient issue or a more persistent challenge impacting European performance.